Skip to content

Clinical trials

Phase 2 Psychotic Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Psychotic Disorders Phase: Phase 2 Clear all

128 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20023
20032
20049
20059
20067
20079
20085
20094
20104
20116
20126
20134
20147
20157
20162
20175
20184
20195
20207
20212
20225
20232
20242
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed92
Terminated14
Recruiting6
Unknown status6
Withdrawn5
Active, not recruiting3
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
MapLight Therapeutics4
NYU Langone Health4
Yale University4
ACADIA Pharmaceuticals Inc.3
China Medical University Hospital3
Mclean Hospital3
Nathan Kline Institute for Psychiatric Research3
Pakistan Institute of Living and Learning3
Sheppard Pratt Health System3
Solvay Pharmaceuticals3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Psychotic Disorders128
Schizophrenia91
Bipolar Disorder18
Mental Disorders17
Hallucinations8
Alzheimer Disease5
Parkinson Disease5
Schizophrenia Spectrum and Other Psychotic Disorders5
Brain Diseases4
Central Nervous System Diseases4

Trials

Showing 51 to 75 of 128. Each trial links to its page on Pharma Observatory.

28 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.